Botanix soars after pot-up-nose study success

Botanix Pharmaceuticals (ASX:BOT) shares have soared after a small clinical trial backed the feasibility of putting synthetic cannabis up the … Read More

The post Botanix soars after pot-up-nose study success appeared first on Stockhead.

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *